Skip to main content
RNA logo

RNA · Atrium Therapeutics, Inc. · Financials

Track RNA — free
$10.36 +0.01 (+0.10%) At close · Sep 11
Market Cap
$177.21M
Shares
17.11M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Chart any reported metric, KPI or segment over time — the full statement history lives here

No structured figures reported for this view yet.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 2093101 CUSIP 04965N104 13F (30d) 64 filings 64 filers Visit website Investor relations